LAMBETH WALK GROUP PRACTICE
5 LAMBETH WALK, LONDON
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 42 | 57 | 73.7% | |
| STROKE 9 | 2006 | 52 | 67 | 77.6% | |
| Stroke 12 | 2007 | 43 | 51 | 84.3% | |
| Stroke 12 | 2008 | 39 | 41 | 95.1% | |
| Stroke 12 | 2009 | 37 | 39 | 94.9% | |
| Stroke 12 | 2010 | 36 | 41 | 87.8% | |
| STROKE 12 | 2011 | 34 | 34 | 100.0% | |
| STROKE 12 | 2012 | 36 | 37 | 97.3% | |
| STROKE 12 | 2013 | 37 | 41 | 90.2% | |
| STIA007 | 2014 | 38 | 39 | 97.4% | |
| STIA007 | 2015 | 37 | 37 | 100.0% | |
| STIA007 | 2016 | 45 | 46 | 97.8% | |
| STIA007 | 2017 | 40 | 40 | 100.0% | |
| STIA007 | 2018 | 50 | 51 | 98.0% | |
| STIA007 | 2019 | 53 | 60 | 88.3% | |
| STIA007 | 2020 | 58 | 68 | 85.3% | |
| STIA007 | 2021 | 64 | 77 | 83.1% | |
| STIA007 | 2022 | 67 | 82 | 81.7% | |
| STIA007 | 2023 | 73 | 85 | 85.9% |
